Yizhang Zhu is a Vice President at 中信证券 with nine years of experience blending quantitative biology and healthcare securities analysis. Trained as a PhD in Systems Biomedicine from Peking University and holding dual undergraduate degrees in economics and basic medical science, he bridges multi-omics data expertise (genomics, transcriptomics, proteomics) with investment research. His career spans academic research at Weill Cornell Medicine and hands-on industry roles, where he has produced IPO inquiry reports, investment strategies, and helped grow digital engagement for research communications. Known for mining complex biological datasets to inform market forecasts, he brings a rare combination of bench-to-market insight that informs healthcare investment decisions. A Pudong-based analyst with a curious, persistent streak (self-described on GitHub as "Persistent Head Damage"), he pairs scientific rigor with practical financial acumen.
9 years of coding experience
Bachelor of Economics (Dual Major), Economics, GPA:3.1, Bachelor of Economics (Dual Major), Economics, GPA:3.1 at 北京大学
Doctor of Philosophy - PhD, Systems Biomedicine, Doctor of Philosophy - PhD, Systems Biomedicine at 北京大学医学部
Contributions:5 PRs, 13 pushes, 1 branch in 25 days
translationsrtgithub-classroom
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.